The present study explores the mechanisms responsible for the fatty liver setup in mice fed trans-10,cis-12-C 18:2 (t10c12 CLA) hypothesizing that an induction of LDL receptor (LDLR) expression is associated to lipid accumulation. In this goal, the effects of t10c12CLA treatment on lipid parameters, serum lipoproteins and expression of liver lipid receptors were measured in LDLR -/-apoB 100/100 mice, as a model of human familial hypercholesterolemia itself LDLR-depleted.
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Conjugated linoleic acids (CLA) refer to a group of dienoic derivatives of linoleic acid. In most of the feeding studies, CLA are mainly represented by cis-9,trans-11-C 18:2 , the main natural isomer produced in ruminants and by trans-10,cis-12-C 18:2 (t10c12 CLA) essentially originating from vegetable oil process. These isomers of linoleic acid have been shown to exhibit a variety of unique properties such as anti-cancer (1), anti-atherogenic (2), and immune response enhancing effects (3) in animal models. CLA have also been reported to reduce total body fat content in mice, rats and chickens (4) (5) (6) . The C57Bl6 mouse is a model largely employed to study the biological effects of CLA which this strain is very sensitive to and in particular to t10c12 CLA recently identified as the isomer affecting body lipid metabolism (7, 8) . After a 4-week treatment with t10c12 CLA, C57Bl6 mice exhibit a severe lipoatrophy, a steatotic liver, a hyperinsulinemia and a plasma triglyceride (TG) alteration (7, 9) . In that way, t10c12 CLA fed mice constitute an interesting model for the study of the steatosis onset in relation with lipid metabolism dysfunctions, non-alcoholic fatty liver disease being now recognized as one of the common features of the metabolic syndrome, with visceral fat obesity, insulin resistance, dyslipidemia, and hypertension (10) . In a previous work, we suggested that a high uptake of plasma lipids by the liver would explain part of the TG accumulation in this organ after t10c12 CLA feeding (7) . As the overexpression of hepatic LDL receptor (LDLR) was demonstrated to increase the clearance of apoB100-containing lipoproteins in mice (11) and since CLA treatment was found to induce the expression of LDLR (7), the liver steatosis onset could depend, at least in part, on this lipoprotein receptor. mice as compared to normal wild-type ones.
Our results show first that LDLR deficiency was unable to prevent the steatosis induced by t10c12 CLA, then that other proteins surrogate LDLR in lipoprotein clearance to such an extent that serum TG levels were even significantly reduced in these mice usually exhibiting high levels of circulating apoB100-rich lipoproteins.
MATERIALS AND METHODS

Animals and treatments
Official French regulations (n° 87848) for the use and care of laboratory animals were followed throughout. The mouse strain used in this study (B6;129S-Apobtm2SgyLdlrtm1Her) originated from Jackson Laboratory (Maine, USA). These mice are deficient in LDLR and expressed only apoB100 (LDLR -/-apoB 100/100 mice). Wild-type C57BL/6 mice originate from Centre d'élevage Dépré (Saint Doulchard, France). After one week of adaptation to the control diet (AO4, UAR, Epinay-sur-Orge, France), 7 week-old male mice were housed in individual plastic cages. LDLR -/-apoB 100/100 mice were randomly allocated to the control or CLA diet (n=5 for each), consisting in a basal diet, whose detailed composition has been previously described (13) , enriched with 1% of C 18:1 n-9 (oleic acid) or trans-10,cis-12-C 18:2 , both esterified as TG. CLA-fed LDLR -/-apoB 100/100 mice and their corresponding controls were sacrificed after 2 or 4 weeks. Wild-type C57BL/6 mice (n=5), fed only the control diet, were used after 4 weeks. Mice were food-deprived 4 h before sacrifice, and anesthetized with ketamine / xylazine (7.5 mg / 1 mg per 100 g of body weight). For lipid analysis, liver, heart, gastrocnemius and blood (collected from the vena cava) were stored at -80°C. Fresh samples 
Lipid analysis
Total liver, muscle and heart lipids were extracted according to Folch (14) . For Liver, total lipids were determined by gravimetry and lipid classes were quantified by the TLC-FID method (15) . Phospholipids, cholesteryl esters and TG were separated by TLC on silica plates (Merck, Darmstadt, Germany). Their constitutive FA were methylated following the procedure of Christie et al. (16) and analysed by GLC as previously described (17) . For skeletal muscle and heart, aliquots of total lipid extracts were resuspended in a solution of Triton-X100 as described in (18) . Then TG contents were measured using a commercial kit 
Serum lipoprotein analysis
Serum lipoprotein analysis was performed by fast performance liquid chromatography (FPLC) and total cholesterol was quantified with an inline detection system as previously described (19) .
Liver lipolytic activity
The procedure used was adapted from that of Iverius et al.(20) . Lipolytic activity determined on tissue homogenates corresponded to amounts of [
CPT I activity and palmitate oxidation rate
Measurements of carnitine palmitoyltransferase I (CPT I) activity and palmitate oxidation rates were performed as previously described (13) . FA oxidation was measured with whole liver homogenates using two media, the first allowing mitochondrial and peroxisomal activities to occur, the second allowing the peroxisomal activity only (21) , and with liver mitochondrial fractions. Protein concentrations of mitochondrial fractions were measured using the bicinchoninic acid procedure (BCA, Sigma) (22) .
Western blot analysis of VLDLR
About 100 mg of frozen liver were quickly homogenized with a mini-beadbeater (BioSpec Protein concentrations of supernatants were measured by the BCA procedure after trichloracetic acid precipitation to eliminate incompatible substances.
Gene expression
Total mRNA was extracted from liver by the Tri-Reagent method adapted from the procedure of Chomczynski and Sacchi (24) . Tri-Reagent was provided by Euromedex (Souffelweyersheim, France). Total mRNA were reverse-transcripted using Iscript cDNA kit (Bio-Rad). Real-time PCR was performed as previously described (19) . Primer pairs were designed using 'Primers!' software and were synthesized by MWG-Biotech AG (Ebersberg, 
Statistics
Differences in mean values between groups were tested by one way ANOVA.
Significant differences between means were tested by Student's t test for an independent variable. When variances were unequal, means were tested by a Kruskal-Wallis nonparametric test. mice for the two durations of treatment. The drastic reduction of epididymal adipose tissue weights and the concomitant liver steatosis usually found in wild-type mice fed t10c12 CLA were also observed in the transgenic model. After 2 weeks of CLA feeding, adipose tissue and liver relative weights were already markedly altered (-62 and + 56%, respectively), these effects being still more pronounced after 4 weeks (-82 and +97%, respectively) ( Table 1 ). The liver TG content increased with the treatment duration and the TG enrichment found in mice fed t10c12 CLA for 4 weeks was even greater than that measured under the same experimental conditions with wild-type mice (13 fold vs 7.5 fold(7), respectively). It is worth noting that the t10c12 CLA treatment also increased liver cholesteryl ester contents, but did not affect the free cholesterol ones. In order to whether a lipid accumulation occurred in tissues other than the liver, the TG content of heart and skeletal muscle was measured. Contrary to the liver, heart and muscle did not accumulate TG in response to CLA feeding, muscle TG levels being even 6 fold reduced.
RESULTS
Effect
In LDLR -/-apoB 100/100 mice, as serum lipid parameters are modified with the ageing, data from control and CLA fed mice were compared for a same treatment duration. Indeed, Table 1 shows that the effect of t10c12 CLA on serum TG levels was dependent on the duration of the treatment since TG were increased after 2 weeks and decreased after 4 weeks, relative to the control series. Levels of total cholesterol, free FA or glycerol in serum were unaltered after 2 weeks of treatment, but were significantly decreased when t10c12 CLA was administered for 4 weeks.
Lipoprotein profile analysis (Figure 1) indicates that VLDL-cholesterol (VLDL-C) and HDL-C levels were increased in the serum of mice fed t10c12 CLA for 2 weeks (+165 and 22%, respectively), whereas LDL-C was slightly decreased, but not significantly.
Besides, when mice were fed for 4 weeks, cholesterol levels were decreased in all fractions, particularly in apoB100 lipoproteins (VLDL-C, -78% ; LDL-C, -41% ; HDL-C, -26%, relative to controls).
Effect of t10c12 CLA feeding on liver FA oxidation in LDLR -/-apoB 100/100 mice Administration of t10c12 CLA improved both peroxisomal and mitochondrial palmitate oxidation rates as measured using liver homogenates both after 2-or 4-week treatment (Table 2) . Similarly, carnitine-dependent palmitate oxidation rates measured using isolated mitochondria were also increased, as well as CPT I activities in the t10c12 CLA series ( Table 2) 
DISCUSSION
In wild-type mice, t10c12 CLA feeding induced a severe lipoatrophy with a concomitant liver steatosis and we previously showed that mRNA levels of LDLR were induced, suggesting an increase in lipoprotein uptake by hepatocytes (7) . In this study, the fact that a liver TG accumulation was recovered even in the absence of LDLR, raises the question of how hepatocytes manage to face the high flux of lipids that were not stored any more in adipose tissues of t10c12 CLA-fed mice. Because the liver steatosis seems to be related to lipoatrophy, one could think that hepatocyte TG accumulation did not result from a direct action of t10c12 CLA on liver cells, but rather from the consequence of mechanisms altering the adipose tissue.
Liver steatosis may also originate from a reduction of lipoprotein secretion rates, from an inhibition of FA ß-oxidation, from high rates of de novo lipogenesis and/or from high lipid uptake. Feeding mice with t10c12 CLA did not reduce liver lipoprotein secretion (7) 22.3 vs 5.62, respectively; data not shown). Indeed, in a recent study, it was hypothesized that the conversion of excess glucose to FA and the storage as TG in the liver, rather than in adipose tissue, could be the mechanism leading to the liver fat accumulation (9) . Therefore the present data also support the conclusion that lipids diverted from adipose tissues, and available for other organs as the liver, might contribute to a large extent to hepatic lipid accumulation. Consistent with this hypothesis, we did not observe any lipid accumulation in (36, 37) . Therefore, the induction of FAT/CD36 and LPL could be related to the greater delivery of FA to liver cells. This seems to particularly apply to FAT/CD36 whose mRNA levels increased concomitantly with the liver TG infiltration (Figure 6 ).
Interestingly, the comparison of gene expression between wild-type and LDLR -/-apoB 100/100 mice indicates that LRP mRNA levels were comparable which does not ascribe any apparent role for LRP in the metabolism of apoB100-containing lipoproteins, even in the absence of LDLR as it was previously reported (38) . However, mRNA levels of LRP increased after 4 weeks of t10c12 CLA treatment, suggesting that LRP stimulation could be secondary to the establishment of CLA-induced hyperinsulinemia (9) as it has been demonstrated in adipocytes (39) and that this receptor likely also participate to the clearance of lipoproteins.
Surprisingly, mRNA levels of HL, which could also provide an alternative clearance pathway for apoB100-containing lipoproteins independent of LDLR (40), were not induced in LDLR -/-apoB 100/100 and even decreased after t10c12 CLA feeding. This support the possibility that HL would be inversely regulated to the cholesterol supply (41) . The same hypothesis could be retained to explain the SR-B1 down-regulation since convergent arguments support the view that HL and SR-B1 would be co-expressed to exert coordinate functions in cell cholesterol homeostasis (42) .
According to our data, the over-expression of VLDLR, LPL and FAT/CD36 observed in LDLR -/-apoB 100/100 mice after 4 weeks of CLA feeding would accelerate liver lipoprotein clearance to such an extent that the elevated serum TG levels observed after 2 weeks of CLA feeding became lower than in controls. It is worth noting that this TG lowering coincides with the nearly complete absence of adipose tissue. Under these conditions, the release of free FA from adipose tissue was necessarily decreased, reducing the lipid flux to the liver and the consecutive VLDL secretion rates when compared to the 2-week series. In the whole, we mice relative to wild-type mice after normalization to ß-actin levels. *Significant differences at p<0.05 vs wild-type. Tables   Table 1 Body, liver and serum parameters in LDLR
